Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Yassin SA, Aroda VR

Drug Design, Development and Therapy 2017, 11:923-937

Published Date: 21 March 2017